Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angeliki Giannelou

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Opinion in Allergy and Clinical Immunology|October 23, 2014
When less is more: primary immunodeficiency with an autoinflammatory kickAngeliki Giannelou, Qing Zhou, Daniel L Kastner
The Lancet. Rheumatology|June 22, 2025
Sarilumab in relapsing polymyalgia rheumatica: patient-reported outcomes from a phase 3, double-blind, randomised controlled trialVibeke Strand, Jerome Msihid, Jennifer Sloane, et al.
Hypertension (Dallas, Tex. : 1979)|January 28, 2009
Exercise capacity and mortality in hypertensive men with and without additional risk factorsPeter Kokkinos, Athanasios Manolis, Andreas Pittaras, et al.
Immunology Letters|November 1, 2011
Potential role for alternatively activated macrophages in the secondary bacterial infection during recovery from influenzaWilbur H Chen, Franklin R Toapanta, Kari Ann Shirey, et al.
Arthritis Research & Therapy|October 15, 2023
A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritisWolfgang A Schmidt, Bhaskar Dasgupta, Jennifer Sloane, et al.
The New England Journal of Medicine|October 4, 2023
Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid TaperRobert F Spiera, Sebastian Unizony, Kenneth J Warrington, et al.
Arthritis Care & Research|November 14, 2025
Sarilumab in Polyarticular-Course Juvenile Idiopathic Arthritis: Dose-Finding and One-Year Analysis of a Phase 2b, Open-Label, Multicenter StudyFabrizio De Benedetti, Inmaculada C Penadés, Irina Nikishina, et al.
The New England Journal of Medicine|December 22, 2022
Dupilumab in Adults and Adolescents with Eosinophilic EsophagitisEvan S Dellon, Marc E Rothenberg, Margaret H Collins, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 26, 2022
Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical TrialSumathi Sivapalasingam, David J Lederer, Rafia Bhore, et al.
Annals of the Rheumatic Diseases|January 24, 2018
Aberrant tRNA processing causes an autoinflammatory syndrome responsive to TNF inhibitorsAngeliki Giannelou, Hongying Wang, Qing Zhou, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Opinion in Allergy and Clinical Immunology|October 23, 2014
When less is more: primary immunodeficiency with an autoinflammatory kickAngeliki Giannelou, Qing Zhou, Daniel L Kastner
The Lancet. Rheumatology|June 22, 2025
Sarilumab in relapsing polymyalgia rheumatica: patient-reported outcomes from a phase 3, double-blind, randomised controlled trialVibeke Strand, Jerome Msihid, Jennifer Sloane, et al.
Hypertension (Dallas, Tex. : 1979)|January 28, 2009
Exercise capacity and mortality in hypertensive men with and without additional risk factorsPeter Kokkinos, Athanasios Manolis, Andreas Pittaras, et al.
Immunology Letters|November 1, 2011
Potential role for alternatively activated macrophages in the secondary bacterial infection during recovery from influenzaWilbur H Chen, Franklin R Toapanta, Kari Ann Shirey, et al.
Arthritis Research & Therapy|October 15, 2023
A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritisWolfgang A Schmidt, Bhaskar Dasgupta, Jennifer Sloane, et al.
The New England Journal of Medicine|October 4, 2023
Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid TaperRobert F Spiera, Sebastian Unizony, Kenneth J Warrington, et al.
Arthritis Care & Research|November 14, 2025
Sarilumab in Polyarticular-Course Juvenile Idiopathic Arthritis: Dose-Finding and One-Year Analysis of a Phase 2b, Open-Label, Multicenter StudyFabrizio De Benedetti, Inmaculada C Penadés, Irina Nikishina, et al.
The New England Journal of Medicine|December 22, 2022
Dupilumab in Adults and Adolescents with Eosinophilic EsophagitisEvan S Dellon, Marc E Rothenberg, Margaret H Collins, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 26, 2022
Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical TrialSumathi Sivapalasingam, David J Lederer, Rafia Bhore, et al.
Annals of the Rheumatic Diseases|January 24, 2018
Aberrant tRNA processing causes an autoinflammatory syndrome responsive to TNF inhibitorsAngeliki Giannelou, Hongying Wang, Qing Zhou, et al.
Pageof 1